Global Autoinjectors Market Size, Share, Demands, Trends, Growth Rate, Key Players and Forecasts to 2028

The global autoinjector devices market is projected to reach USD 1.7 billion in 2028 from USD 0.9 billion in 2023, growing at a CAGR of 14.0%. Whereas, the autoinjector finished formulations market is projected to reach USD 136.5 billion in 2028 from USD 59.6 billion in 2023, growing a CAGR of 18.0%. The key factors driving the growth of the autoinjectors market are the increasing availability of generic versions of autoinjectors and advantages offered by autoinjectors in emergency medical care is expected to propel the growth of the market. However, alternative modes of drug delivery such as oral, nasal, and topical among others are expected to restrain market growth to a certain extent.

Download a FREE Sample Copy of the Global Autoinjectors Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1592468

The autoinjectors market has been segmented based on technology, usage, route of administration, volume, therapy area, end user and region.

Prominent Players:

Becton, Dickinson and Company (BD) (US)
Ypsomed Holding AG (Switzerland)
sSHL Medical (Switzerland)
West Pharmaceutical Services, Inc. (US)
Recipharm AB (Sweden)
Haselmeier GmbH (Germany)
Owen Mumford Ltd. (UK)
Gerresheimer AG (Germany)
Phillips-Medisize, LLC (US)
Oval Medical Technologies Ltd. (UK)
Kaleo, Inc. (US), Solteam Incorporation Co., Ltd. (China)
Elcam Drug Delivery Devices (E3D) (Israel)
Crossject (France)
Johnson MedTech, LLC. (US), Antares Pharma, Inc. (US)
Jabil, Inc. (US)
Congruence Medical Solutions LLC (US)
AbbVie Inc. (US)
Amgen Inc. (US)
Eli Lilly and Company (US)
Novartis AG (Switzerland)
Merck KGaA (Germany)
Viatris Inc. (US)
Biogen (US)

The autoinjectors market refers to the industry involved in the manufacturing, distribution, and sale of autoinjector devices. Autoinjectors are medical devices designed to deliver a pre-measured dose of a specific medication or therapeutic agent. They are designed to be user-friendly, allowing patients or caregivers to administer medications easily and accurately.

Autoinjectors are commonly used for the self-administration of medications, such as emergency treatments, vaccines, hormonal therapies, and biologic drugs. The device typically consists of a pre-filled syringe or cartridge, a needle, and an automated mechanism that delivers the medication quickly and safely with minimal effort.

The market for autoinjectors is expected to continue growing due to various factors, such as an aging population, increasing prevalence of chronic diseases, and advancements in drug delivery technologies. Additionally, the COVID-19 pandemic has emphasized the need for self-administration of vaccines, further driving the demand for autoinjectors. The market is also witnessing developments in connected autoinjectors, which incorporate digital features and connectivity for tracking adherence, monitoring usage, and improving patient outcomes.

Direct Purchase of the Global Autoinjectors Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1592468

+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.